Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Catestatin (human)

 
BML-CP6420-0001 1 mg 297.00 USD
Do you need bulk/larger quantities?
 
Human Chromogranin A [352-372]). Wild type catestatin, initially described as a potent catecholamine release inhibitory peptide. Cst located in the skin is active against Gram-negative and Gram-positive bacteria as well as against fungi and yeast. Also proposed as a modulator or regulator of cardiac function and as an anti-hypertensive agent.

Product Specification

Alternative Name:Chromogranin A (352-372)
 
Sequence:H-Ser-Ser-Met-Lys-Leu-Ser-Phe-Arg-Ala-Arg-Ala-Tyr-Gly-Phe-Arg-Gly-Pro-Gly-Pro-Gln-Leu-OH (human Chromogranin A[352-372])
 
Formula:C104H164N32O27S1
 
MW:2326.7
 
Formulation:Lyophilized.
 
Purity:≥98% (HPLC)
 
Appearance:Solid.
 
Solubility:Soluble in Water.
 
Shipping:Shipped on Blue Ice
 
Long Term Storage:-20°C
 

Product Literature References

Formation of the catecholamine release-inhibitory peptide catestatin from chromogranin A. Determination of proteolytic cleavage sites in hormone storage granules: C.V. Taylor, et al.; J. Biol. Chem. 275, 22905 (2000), Abstract; Full Text
Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist: S.K. Mahata, et al.; J. Clin. Invest. 100, 1623 (1997), Abstract; Full Text
Secretion from chromaffin cells is controlled by chromogranin A-derived peptides: J.P. Simon, et al.; Proc. Natl. Acad. Sci. USA 85, 1712 (1988), Abstract; Full Text
The primary structure of human chromogranin A and pancreastatin: D.S. Konecki, et al.; J. Biol. Chem. 262, 17026 (1987), Abstract; Full Text

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,